Monoclonal antibody NU-B1 reacts with novel antigen on human B cells in mantle and marginal zones distinct from known CD molecules

Tissue Antigens

Volumn 52, Issue 5, 1998, Pages 422-429

  Matsuo, Y ^a   Sugimoto, A ^a   Kuwahara, K ^b   Watanabe, Y ^b   Sakata, A ^b   Sakaguchi, N ^b   Sagawa, K ^c   Orita, K ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Differentiation antigen; Human B cell; Leukemia lymphoma; Mantle zone; NU B1

Indexed keywords

ANTIGEN; B LYMPHOCYTE ANTIGEN; CD20 ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; FC RECEPTOR; HLA DR ANTIGEN; MONOCLONAL ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; ERYTHROCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOLOGY; IMMUNOPRECIPITATION; LYMPH NODE; MONOCYTE; MONONUCLEAR CELL; MULTIPLE MYELOMA; NEUTROPHIL; PRIORITY JOURNAL; THYMOCYTE; TONSIL CELL;

EID: 0031743735     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03068.x     Document Type: Article

References (22)

1. Schlossman SF, Boumsell L, Gilks W et al., eds. Leukocyte typing V. Oxford: Oxford University Press, 1995.
2. Engel P, Wagner N, Tedder TF. CD79 workshop report. In: Schlossman SF, Boumsell L, Gilks W, et al., ed. Leukocyte typing V. Oxford: Oxford University Press, 1995: 667-70.
3. Okazaki M, Luo Y, Han T, Yoshida M, Seon BK. Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalized after binding to the cell surface antigen. Blood 1993: 81: 84-94.
4. Astsaturov IA, Matutes E, Morilla R et al. Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukemia. Leukemia 1996: 10: 769-73.
5. Zomas AP, Matutes E, Morilla R, Owusu-Ankomah K, Seon BK, Catovsky D. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia 1996: 10: 1966-70.
6. Wagner N, Engel P, Tedder TF. Biochemical analysis of mAb of the workshop B-cell unknown and cytoplasmic panels. In: Schlossman SF, Boumsell L, Gilks W et al., eds. Leukocyte typing V. Oxford: Oxford University Press, 1995: 636-42.
7. Nadler LM, Anderson KC, Marti G et al. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 1983: 131: 244-50.
8. Stamenkovic I, Seed B. CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail. J Exp Med 1988: 168: 1205-10.
9. Kohno S, Minowada J, Sandberg AA. Chromosome evolution of near-haploid clones in an established human acute lymphoblastic leukemia cell line (NALM-16). J Natl Cancer Inst 1980: 64: 485-93.
10. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975: 256: 495-7.
11. Kuwahara K, Matsuo T, Nomura J et al. Identification of a 52-kDa molecule (p52) coprecipitated with the Ig receptor-related MB-1 protein that is inducibly phosphorylated by the stimulation with phorbol myristate acetate. J Immunol 1994: 152: 2742-52.
12. Ezaki T, Yao L, Matsuno K. The identification of proliferating cell nuclear antigen (PCNA) on rat tissue cryosections and its application to double immunostaining with other markers. Arch Histol Cytol 1995: 58: 103-15.
13. Bene MC, Castoldi G, Knapp W et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemia (EGIL). Leukemia 1995: 9: 1783-86.
14. Kansas GS, Wood GS, Tedder TF. Expression, distribution, and biochemistry of human CD39: role in activation-associated homotypic adhesion of lymphocytes. J Immunol 1991: 146: 2235-44.
15. Dunn D, Dogan A, Issacson PG, Spencer J. B-cell unknown panel: immunohistochemical analysis of normal tonsil and spleen and lymphomas of marginal zone lineage. In: Schlossman SF, Boumsell L, Gilks W et al., ed. Leukocyte typing V. Oxford: Oxford University Press, 1995: 653-55.
16. Persin C, Jensen WA, Cambier JC. Definition of the submolecular specificity of mAb against mb1 (Igα) and B29 (Igβ/γ). In: Schlossman SF, Boumsell L, Gilks W et al., ed. Leukocyte typing V. Oxford: Oxford University Press, 1995: 670-73.
17. Nakamura T, Kubagawa H, Cooper MD. Heterogeneity of immunoglobulin-associated molecules on human B cells identified by monoclonal antibodies. Proc Natl Acad Sci U S A 1992: 89: 8522-26.
18. +, and κ λ) from acute leukemia. Leukemia 1995: 10: 700-6.
19. Matsuo Y, MacLeod RAF, Kojima K et al. A novel ALL-L3 cell line, BALM-16, lacking expression of immunoglobulin chains derived from a patient with hypercalcemia. Leukemia 1997: 11: 2168-74.
20. Garcia-Conde J, Cabanillas F. Mantle cell lymphoma: a lymphoproliferative disorder associated with aberrant function of the cell cycle. Leukemia 1996: 10: S78-S83.
21. Meusers P, Hense J, Brittinger G. Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems. Leukemia 1997: 11: S60-S64.
22. Pittaluga S, Bijnens L, Teodorovic I et al. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the revised European-American classification of lymphoid neoplasms: a comparison with the working formulation. Blood 1996: 87: 4358-67.